Filter By Industry
Filter By Tag

Newsroom

Curtana Pharmaceuticals Press releases

1 - 1 of 1 Press Release

Preprint Reports Curtana's CT-179 Enhances Radiotherapy in an MGMT-Unmethylated Glioblastoma Model and Extends Survival as a Single Agent
Oct 27, 2026
Foundational preclinical study of the first-in-class, brain-penetrant OLIG2 inhibitor supports evaluating CT-179 with standard-of-care therapy, including in MGMT-unmethylated glioblastoma, where temozolomide adds little


Curtana Pharmaceuticals RSS Feed